Literature DB >> 7201823

Chemotherapeutic activity of 2-chloroethylnitrosocarbamoyl derivatives of amino acids in a transplanted rat leukemia (L 5222).

W J Zeller, M Berger, G Eisenbrand, W Tang, D Schmähl.   

Abstract

The therapeutic activity of a single-dose treatment with 14 2-chloroethylnitrosocarbamoyl derivatives of amino acids (CNU-analogs) in L 5222 rat leukemia is presented. Compounds under study included free carboxylic acids, a methylester, a toluidide, four glucosamides and one derivative of a dipeptide. All substances proved to be active effecting at least an increase in life span of greater than or equal to 120% compared with untreated controls at the optimal dose; 2 compounds effected isolated cures (90-day survivors). Compared with previous data obtained with established and new nitrosoureas under the same conditions, the effectivity of the compounds presented here should be classified, however, only as moderate.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7201823

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  Antitumor action of N-(2-chloroethyl)-N-nitrosocarbamoyl derivatives of biologically active polypeptide hormone fragments.

Authors:  A Jeney; L Kopper; P Nagy; K Lapis; H Süli-Vargha; K Medzihradszky
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Cytostatic activity of steroid linked nitrosoureas.

Authors:  W J Zeller; J Schreiber; A D Ho; D Schmähl; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

3.  New derivatives of CNC-amino acids and -oligopeptides: experimental antitumor activity.

Authors:  W J Zeller
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

4.  Antineoplastic activity of esters and amides of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-aminoacids.

Authors:  W J Zeller; K Ehresmann; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.